, Expertise collective : tabac. Comprendre la dépendance pour agir. Paris: Éditions Inserm, 2001.

J. P. Tassin, Proposition d'un modèle neurobiologique de l'addiction, Psychotropes, vol.14, pp.11-28, 2008.
DOI : 10.3917/psyt.143.0011

C. Lanteri, L. Salomon, and Y. Torrens, Drugs of abuse specifically sensitize noradrenergic and serotonergic neurons via a non-dopaminergic mechanism, Neuropsychopharmacology, vol.33, pp.1427-1461, 2008.

L. Moal and M. , Théories neurobiologiques de l'addiction, Traité d'Addictologie, 2006.

N. L. Benowitz, Nicotine addiction, N Engl J Med, vol.362, pp.2295-303, 2010.

J. P. Tassin and F. La-lettre-du-collège-de, Hors Série -Fév, pp.28-39, 2010.

C. Lanteri, H. Vallejo, S. J. Salomon, and L. , Inhibition of mono amine oxydases desensitizes 5-HT1A auto receptors an allows nicotine to induce a neurochemical and behavioural sensitization, J Neurosci, vol.29, pp.987-97, 2009.

A. J. Oliveira-maia, J. R. Stapleton-kotloski, and V. Lyall, Nicotine activates TRPM5-dependent and independent taste pathways, Proc Natl Acad Sci, vol.106, pp.1596-601, 2009.
DOI : 10.1073/pnas.0810184106
URL : http://www.pnas.org/content/106/5/1596.full.pdf

H. J. Aubin, Nicotine et troubles neuropsychiatriques, 1997.

L. Strat, Y. Gorwood, and P. , Vulnerability genetique au tabagisme, Arrêt du tabac chez les patients atteints d'affections psychosomatiques. Conférence d'experts, 2009.

Y. Liu, W. Wen, and M. A. James, Aplotype and cell proliferation analyses of candidate lung cancer susceptibility genes on chromosome 15q24-25.1, Cancer Res, vol.69, pp.844-50, 2009.

G. Lagrue and . Tabagisme, Traité d'Addictologie, 2006.

C. Xirassavidou, Y. Khassal, and D. Zullino, « L'hyperautomatisation » une voie de compréhension des mécanismes de l'addiction, Alcool Addictol, vol.31, pp.243-249, 2009.

G. E. Woody, Severity of dependence, Data from DSM IV. Addiction, vol.88, pp.1573-1582, 1993.

K. O. Fagerström, T. F. Heatherton, and L. T. Kozlowski, Nicotine addiction and its assessment, Ear Nose Throat J, vol.69, pp.783-788, 1990.

T. F. Heatherton, L. T. Kozlowski, and R. C. Frecker, The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire, Br J Addict, pp.1119-1146, 1991.

I. Berlin, F. Vorspan, and E. G. Singleton, Reliability and Variety of the French Version of Tobacco Craving Questionnaire, Eur Addict Res, vol.11, pp.62-70, 2005.

R. West and M. Ussher, Is the ten Questionnaire of Smoking Urges (QSU brief) more sensitive to abstinence than shorter creaving measure?, Psychopharmacology, vol.208, pp.427-460, 2010.

J. F. Etter, T. V. Perneger, and A. Ronchi, Distributions of smokers by stage international comparison and association with smoking prevalence, Prev Med, vol.26, pp.580-585, 1997.

J. Perriot, La conduite de l'aide au sevrage tabagique, Rev Mal Respir, vol.23, pp.3-85, 2006.
DOI : 10.1016/s0761-8425(06)73419-2

M. Underner and G. Peiffer, Petits fumeurs et fumeurs intermittents, Rev Mal Respir, vol.27, pp.1150-63, 2010.
DOI : 10.1016/j.rmr.2010.10.003

D. F. Seidman and L. S. Covey, Helping the Hard-core smoker. A Clinician's Guide, 1999.

M. L. Costa, J. E. Cohen, and M. O. Chalton, Hardcore'' definitions and their application to a population-based sample of smokers, Nicotine Tob Res, vol.12, pp.860-864, 2010.

S. Emery, E. A. Gilpin, and C. Ake, Characterising and identifying ''Hard-core Smokers'': implications for further reducing prevalence, Am J Pub Health, vol.90, pp.387-94, 2000.

E. M. Augustson and S. E. Marcus, Use of the current population survey to characterize subpopulations of continued smokers. A national perspective on the ''hard-core'' phenomenom, Nicotine Tob Res, vol.6, pp.621-630, 2004.

M. A. Jarvis, J. Wardle, and J. Waller, Prevalence of hard-core smoking in England and associated attitudes and beliefs: cross sectional study, BMJ, vol.7398, p.1061, 2005.

R. A. Walsh, C. L. Paul, and F. Tzelepis, Quit smoking behaviours and intentions and hard-core smoking in New South Wales, Health Promot J Aust, vol.17, pp.54-60, 2006.
DOI : 10.1071/he06054

A. K. Ferketich, S. Gallus, and P. Collombo, Hardcore smoking among italian men and women, Eur J Cancer Prev, vol.18, pp.100-105, 2009.
DOI : 10.1097/cej.0b013e32830c8d98

M. P. Tavolacci, H. Marini, and L. Bailly, Prévalence et caracté-ristiques des fumeurs invétérés en Haute-Normandie, Sante Publique, vol.6, pp.583-93, 2009.
DOI : 10.3917/spub.096.0583

J. P. Pierce, K. Messer, and M. M. White, Prevalence of heavy smoking in California and the United States, JAMA, vol.305, pp.1106-1118, 1965.

M. L. Sheu, T. W. Hu, and T. E. Keeler, The effect of major cigarette price change on smoking behavior in California: a zero-inflated negative binomal model, Health Econ, vol.13, pp.781-91, 2004.

A. Mc-intosh and T. Coleman, Characteristics and prevalence of hard core smokers attending UK general practitioners, BMC Family Practice, vol.7, p.24, 2006.

J. Perriot, L'aide à l'arrêt du tabagisme des fumeurs irréduc-tibles, Courrier Addict, vol.1, pp.15-22, 2010.

J. Perriot, Sevrage tabagique des patients atteints de BPCO, Courrier Addict, vol.4, pp.161-165, 2004.

E. J. Wagena, I. Kant, and M. J. Huibers, Psychological distress and depressed mood in employees with asthma, chronic bronchitis or emphysema: a population-based observationnal study on prevalence and relation ship with smoking cigarettes, Eur J Epidemiol, vol.19, pp.147-53, 2004.

, Recommandations de la Société de pneumologie de langue française sur la prise en charge de la BPCO, Rev Mal Respir, vol.27, pp.1-87, 2009.

D. Thomas, Tabagisme : facteur de risque cardiovasculaire n o 1, Lettre Pneumologue, vol.2, pp.68-71, 2008.

B. Dautzenberg, Traiter le tabagisme : une priorité en cancé-rologie pulmonaire, Rev Pneumol Clin, vol.60, pp.308-319, 2004.
DOI : 10.1016/s0761-8417(04)72143-4

, Arrêt du tabac chez les patients atteints d'affections psychiatriques. Conférence d'experts, 2009.

G. Lagrue and D. Touzeau, Dépendance tabagique : troubles anxieux et dépressifs, Courrier Addict, vol.12, pp.8-12, 2010.

C. Gillet and . Tabac, alcool et cannabis. Alcool Addictol, vol.29, pp.390-397, 2007.

M. Reynaud and . Traité-d'addictologie, , 2006.

D. Touzeau and G. Lagrue, Prise en charge du tabagisme chez les héroïnomanes en traitement de maintenance, Courrier Addict, vol.12, pp.12-16, 2010.

L. Faou and A. L. , Tabac et populations défavorisées, Courrier Addict, vol.1, pp.104-112, 2002.

J. Adams, The role of time perspective in smoking cessation amongst older English adults, Health Psychol, vol.28, pp.529-563, 2009.

N. Sachs-ericsson, N. B. Schmidt, and M. J. Zvolensky, Smoking cessation behavior in older adults by race and gender: the role of health problem and psychological distress, Nicotine Tob Res, vol.11, pp.433-476, 2009.

J. Donzé, C. Ruffié, and J. Cornuz, Determinants of smoking and cessation in older woman, Age Ageing, vol.36, pp.53-60, 2007.

, Afssaps. Les stratégies thérapeutiques médicamenteuses et non médicamenteuses de l'aide à l'arrêt du tabac, Alcool Addictol, vol.25, pp.3-44, 2003.

, Treating tobacco use and dependence. Clinical Practice Guideline, update, 2008.

C. Silagy, T. Lancaster, and L. Stead, Nicotine replacement therapy for smoking cessation, Cochrane Database Syst Rev, issue.3, p.146, 2004.

I. Berlin, Rationnel physiopathologique de la prise en charge médicamenteuse du sevrage tabagique : développements actuels et futurs, Lettre Pneumologue, vol.XI, pp.84-93, 2008.

J. Medioni, I. Berlin, and A. Mallet, Increased risk of relapse after stopping nicotine replacement therapies: a mathematical modelling approach, Addiction, vol.100, pp.247-54, 2005.

R. A. Schnoll, F. Patterson, and E. P. Wileyto, Effectiveness of extended-duration transdermal nicotine therapy: a randomised trial, Ann Intern Med, vol.152, pp.144-51, 2010.

R. P. Murray, L. B. Gerald, and P. G. Lindgren, Characteristics of participants who stop smoking and sustain abstinence for 1 and 5 years in the Lung Health Study, Prev Med, vol.30, pp.392-400, 2000.

P. Hajek, H. Mc-robbie, and F. Gillison, Dependence potential of nicotine replacement treatments effects of product type, patient characteristics and cost to user, Prev Med, vol.44, pp.230-234, 2007.

L. F. Stead, R. Perera, and C. Bullen, Nicotine replacement therapy for smoking cessation, Cochrane Database Syst Rev, vol.1, p.146, 2008.

J. E. Rose, J. E. Herskovic, and F. M. Behm, Precessation treatment with nicotine patch significantly inoreases abstinence rates relative to conventional treatment, Nicotine Tob Res, vol.11, pp.1069-75, 2009.
DOI : 10.1093/ntr/ntp103

M. M. Schuurmans, A. H. Diacon, and X. Van-biljon, Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial, Addiction, vol.99, pp.634-674, 2004.

L. Galanti, Cotinine urinaire: dosage et applications, Rev Med Gen, vol.251, pp.112-117, 2008.

C. Lerman, C. Jepson, and E. P. Wileyto, Genetic variation in nicotine metabolism predicts the efficacy of extendedduration transdermal nicotine therapy, Clin Pharmacol Ther, vol.87, pp.553-560, 2010.

I. Berlin, N. Jacob, and N. Coudert, Adjustment of Nicotine replacement therapies according to saliva cotinine concentration: the ADONIS trial-a randomized study in smokers with medical comordities, Addiction, vol.106, pp.833-876, 2011.

P. Dupont, Mode d'action de la varénicline et efficacité dans la population générale des fumeurs, Arrêt du tabac chez les patients atteints d'affections psychiatriques. Conférence d'experts, 2009.

J. A. Stapleton, L. Watson, and U. Spirling, Varénicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness, Addiction, vol.103, pp.146-54, 2008.

H. J. Aubin, A. Bobak, and J. R. Britton, Varénicline versus transdermal nicotine patch for smoking cessation: results from a randomised, open-label trial, Thorax, vol.63, pp.717-741, 2008.

S. Rennard, J. Hughes, and P. Cinciripini, for the Flexible Quit Study group, 2010.

N. A. Rigotti, A. Pipe, and N. L. Benowitz, Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease. A randomized trial, Circulation, vol.121, pp.2211-2220, 2010.

D. P. Tashkin, S. Rennard, T. Hays, and J. , Effects of varenicline on smoking cessation in mild-to-moderate COPD: a randomized controlled trail, Chest, vol.139, pp.581-590, 2011.

D. Gunnel, D. Irvine, and L. Wise, Varenicline and suicide behaviour: a cohort study based on data from the General Practice Research Database, BMJ, vol.339, p.3805, 2009.

S. Tonstad, S. Davies, and M. Flammer, Psychiatric adverse events in radomized, double-blind. Placebo-controlled clinical trial of varenicline, Drug Saf, vol.33, pp.289-301, 2010.

S. Tonstad, P. Tonnesen, and P. Hajek, Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial, JAMA, vol.296, pp.64-71, 2006.

E. J. Mills, P. Wu, and D. Spurden, Efficacy of pharmacotherapies for short-term smoking abstinance. A Systematic review and meta-analysis, Harm Reduction, vol.6, pp.1-16, 2009.

G. Peiffer, Le bupropion : mécanismes d'action et efficacité dans le traitement du tabagisme, Arrêt du tabac chez les patients atteints d'affections psychiatriques. Conférence d'experts, 2009.

G. Lagrue and J. Menard, Quel avenir pour un vaccin « anti-tabac » ?, Presse Med, vol.39, pp.289-90, 2010.
DOI : 10.1016/j.lpm.2009.12.003

T. P. George, Medication Treatments for Nicotine Dependence, 2006.

R. M. Anthenelli, T. J. Blom, M. Elroy, and S. L. , Preliminary evidence for gender-specific effects of topiramate as a potential and to smoking cessation, Addiction, vol.103, pp.687-94, 2008.

D. A. Baltieri, F. R. Daro, and P. L. Ribeiro, Effects of topiramate on tobacco use among male alcohol-dependent out patients, Drug Alcohol Depend, vol.105, pp.33-41, 2009.
DOI : 10.1016/j.drugalcdep.2009.05.025

S. S. Smith, D. E. Mc-carthy, and S. J. Japuntich, Comparative effectiveness of 5 smoking cessation pharmacotherapies in primary care clinics, Arch Intern Med, vol.169, pp.2148-55, 2009.

J. O. Ebbert, M. V. Burke, and J. T. Hays, Combination treatment with varenicline and nicotine replacement therapy, Nicotine Tob Res, vol.11, pp.572-578, 2009.
DOI : 10.1093/ntr/ntp042

M. Quaak, C. P. Van-schayck, and A. M. Knapen, Genetic variation as a predictor of smoking cessation success. A promising preventive and intervention tool for chronic respiratory disesases?, Eur Respir J, vol.33, pp.468-80, 2009.

K. J. Jackson, M. J. Marks, and R. E. Vann, Role of alpha 5 nicotine acethylcholine receptors in pharmacological and behavioral effects of nicotine in mice, J Pharmacol Exp Ther, vol.334, pp.137-183, 2010.

R. Exley, N. Maubourguet, and V. David, Distinct contribution of incotine acethylcholine receptor subunit (alpha) 4 and subunit (alpha) 6 to the reinforcing effects of nicotine, Proc Natl Acad Sci, vol.108, pp.7577-82, 2011.

P. Guichenez and A. Stoebner-delbarre, Efficacité des TCC dans l'arrêt du tabac en population générale, Arrêt du tabac chez les patients atteints d'affections psychiatriques. Confé-rence d'experts, 2009.

E. A. Dornelas and J. J. Magnavita, High impact therapy for smoking cessation, J Clin Psychol, vol.57, pp.1311-1333, 2001.

Y. Martinet, A. Bohadana, and N. Wirth, La réduction du risque en tabacologie, Rev Mal Respir, vol.23, pp.13-109, 2006.
DOI : 10.1016/s0761-8425(06)71802-2

J. R. Hughes and J. M. Carpenter, The feasibility of smoking reduction: an update, Addiction, vol.100, pp.1074-1083, 2005.

D. Moore, P. Aveyard, and A. Fry-smith, Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis, BMJ, vol.338, p.1024, 2009.

C. Jimenez-ruiz, S. Solano, and S. A. Viteri, Harm reduction a treatment approach for resistant smokers with tobaccorelated symptoms, Respiration, vol.69, pp.452-457, 2002.

L. Houezec, J. Säwe, and V. , Smoking reduction and tempory abstinence: new approaches for smoking cessation, J Mal Vasc, vol.28, pp.293-300, 2003.

K. O. Fagerström, Can reduced smoking be a way for smokers not interested in quitting to actually quit?, Respiration, vol.72, pp.216-236, 2005.

B. Dautzenberg, Le tabac à sucer, cette drôle d'idée que la Suède veut exporter. Info Respiration (Paris) n o 96, vol.2010

I. Berlin and G. Mathern, Connaissances actuelles des effets sur la santé du tabac oral avec attention particulière au Snus suédois. Rapport de la Société française de tabacologie à la demande de la Direction générale de la santé, 2008.

L. E. Thompson, J. R. Barnett, and J. R. Pearce, Scared straigh, Fearappeal anti smoking campaigns, risk, self-efficacy and addiction, Health Risk Soc, vol.2, pp.181-96, 2010.
DOI : 10.1080/13698570902784281

K. E. Lund, M. Neill, and J. Scheffels, The use of snus for quitting smoking compared with medicinal products, Nicotine Tob Res, vol.12, pp.817-839, 2010.

J. Foulds, L. Ramstrom, and M. Burke, Effect of smokeless tobacco (snus) on smoking and public health in Sweden, Tob Control, vol.12, pp.349-59, 2003.

L. Houezec, J. , M. Neill, J. Britton, and . Tobacco, nicotine and harm reduction, Drug Alcohol Rev, vol.30, pp.1189-223, 2011.

J. Perriot, P. M. Llorca, and D. Boussiron, Tabacologie et sevrage tabagique, 2003.

J. Cooper and R. Borland,

H. H. Yong, To what extent do smokers make spontaneous qui attemps and what are the implications for smoking cessation maintenance? Fiddings form the International Tobacco Control Four country survey, Nicotine Tob Res, vol.12, pp.51-58, 2010.

R. Borland, H. H. Yong, and J. Balmford, Motivational factors predict qui attemps but not maintenance of smoking cessation: filding from the International Tobacco Four country project, Nicotine Tob Res, vol.12, pp.4-11, 2010.

K. A. Perkins, J. Briski, and C. Fonte, Severity of tobacco abstinence symptoms varies by time of day, Nicotine Tob Res, vol.11, pp.84-91, 2009.

M. S. Dumbar, D. Scharf, and T. Kirchner, Do smokers crave cigarettes in some smoking situations more than others? Situational corrrelates of craving when smoking, Nicotine Tob Res, vol.12, pp.226-260, 2010.

J. R. Hughes, Craving among long abstinent smokers: an internet survey, Nicotine Tob Res, vol.12, pp.459-62, 2010.
DOI : 10.1093/ntr/ntq009
URL : http://europepmc.org/articles/pmc2902924?pdf=render

T. Tomson, M. Toftgard, and H. Gilljam, Symptoms in smokers trying to quit, Tob Induc Dis, vol.3, pp.44-58, 2006.
DOI : 10.1186/1617-9625-3-61
URL : https://doi.org/10.1186/1617-9625-3-61

M. E. Piper, T. R. Schlam, and J. W. Cook, Tobacco withdrawal components and their relations with cessation success, Psychopharmacology, vol.216, pp.569-78, 2011.
DOI : 10.1007/s00213-011-2250-3
URL : http://europepmc.org/articles/pmc3139774?pdf=render

D. S. Courvoisier and J. F. Etter, Comparing the predictive validity of five cigarette dependence questionnaires, Drug Alcohol Depend, vol.107, pp.128-161, 2010.

D. M. Bolt, M. E. Piper, and D. E. Mc-carthy, The Wisconsin Predicting Patients' Relapse questionnaire, Nicotine Tob Res, vol.11, p.481492, 2009.
DOI : 10.1093/ntr/ntp030
URL : http://europepmc.org/articles/pmc2671459?pdf=render

M. B. Steinberg, A. C. Schnelzer, and D. L. Richardson, The case for treating tobacco dependence as a chronic disease, Ann Intern Med, vol.148, pp.554-560, 2008.

H. A. Lando, Reflexions on 30 + years of smoking cessation research: from individual to the world, Drug Alcohol Rev, vol.25, pp.5-14, 2006.

R. Hurt, J. O. Ebbert, and J. T. Hays, Treating tobacco dependence in a medical setting, CA Cancer J Clin, vol.59, pp.314-340, 2009.
DOI : 10.3322/caac.20031
URL : http://europepmc.org/articles/pmc3903579?pdf=render

J. Perriot, A. Schmitt, and P. M. Llorca, Comment optimiser la prise en charge du sevrage tabagique, Alcool Addictol, vol.27, pp.201-210, 2005.